Jarkko Ahvonen

5PUBLICATIONS
15CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersEpidemiological modellingMortality
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 19, 2026
How does pulmonary function impact QoL in patients with locally advanced NSCLC treated with chemoradiotherapy and durvalumab?

Frigg Å Sommervoll, Henrik Horndalsveen, Dag Einar Sommervoll

|Sep 28, 2025
Comprehensive Genomic Profiling in Advanced Non-Small Cell Lung Cancer: A Real-World Cohort Study in Finland.

Kirsi Hormalainen, Kaisa Marttila, Matti Nykter

|Jul 17, 2023
Trends in cost of treatment of lung cancer patients in 2014-2019 in Finland - a descriptive register study.

Riikka-Leena Leskelä, Sonja Korhonen, Ira Haavisto

|Jun 17, 2023
The prognostic and predictive roles of plasma C-reactive protein and PD-L1 in non-small cell lung cancer.

Saara Kuusisalo, Antti Tikkanen, Elisa Lappi-Blanco

|May 31, 2023
Survival with lung cancer in Finland has not improved during 2007-2019-a single center retrospective population-based real-world study.

Jarkko Ahvonen, Tiina Luukkaala, Tarja Laitinen

Pageof 1